Retrospective, Observationnal Study to Investigate Procedural Analgesia Delivered to Patients With Lacerations, Abrasions, Burns and Leg Ulcers. (APPABU)

January 9, 2026 updated by: Kolia MILOJEVIC, Versailles Hospital

Retrospective and Observational Category 3 Study to Investigate Procedural Analgesia Delivered to Patients With Skin Injury, Aiming to Describe and Quantify Therapeutic Pain Control Procedures Addressing Skin Lacerations, Abrasions, Burns and Leg Ulcers.

The main part of the study is a retrospective analysis of 200 reports concerning patients with skin wounds and injuries :

  • 50 consecutive patient reports dealing with skin lacerations
  • 50 consecutive patient reports dealing with skin abrasions
  • 50 consecutive patient reports dealing with skin burns
  • 50 consecutive patient reports dealing with leg ulcers

The study comprises a complementary prospective segment, consisting of data collection from patients and from care delivery personnel, threw short interviews, in order to assess the validity of the retrospective recording on reports.

Study Overview

Status

Completed

Detailed Description

The retrospective part of the study consists of data collection regarding care delivered to heal skin injuries.

For procedures performed in the emergency department (wound care, dermabrasions and burns), the main source of collection data will be the computerized emergency files that are completed by the doctors and that meet our objectives. For the care of leg ulcers, the main source of collection are records from vascular medicine consultations, and will be represented by the care files that are filled in by the nurses during the consultation.

In each of the four sections of the survey (wounds, dermabrasions, burns and leg ulcers), 50 "consecutive and correctly completed" acts will be included and will be collected.

Incomplete files (missing data on the procedures performed and/or treatments administered) will be replaced by the following ones in reverse chronological order. Inclusion will start with the most recent files and extend to the oldest ones. When the investigators have doubts about the understanding and correct interpretation of the information in the source files, they will discuss them with the careproviders, on an ad hoc basis and during the scheduled structured interviews.

The prospective part of the study consists of short guided interviews with patients (10-minute conversation with specific formated questions) and with care providers (15-minute conversation). The objective of the interviews is to validate, complete and/or correct the information collected threw patient reports.

Study Type

Observational

Enrollment (Actual)

240

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Le Chesnay, France, 78150
        • Hospital Versailles

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients with skin injuries (consulting emergency departments for skin laceration abrasion or burn, consulting vascular unit for patients with leg ulcer).

Description

Inclusion Criteria:

Main retrospective study: Adult patient with skin injury (laceration, abrasion, burn or skin ulcer) whose medical report is available.

Additionnal prospective interview: Adult patient with skin injury (laceration, abrasion, burn or skin ulcer) who consents to the 10-minute interview.

Exclusion Criteria:

Main retrospective study: medical report incomplete. Additionnal prospective interview: Not french speaking.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Procedural analgesia delivered to patients with dermabrasion
Hospital reports of patients who were treated in the emergency deparment for skin abrasion
Procedural analgesia delivered to patients with skin burn
Hospital reports of patients who were treated in the emergency department for skin burn
Procedural analgesia delivered to patients with leg ulcer
Hospital reports of patients who were treated in the vascular department for leg ulcer
Procedural analgesia delivered to patients with skin lacerations
Hospital reports of patients who were treated in the emergency deparment for skin lacerations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: Up to 30 minutes
Pain level ≤ 3/10 (light or no pain) on a 10-point pain scale throughout the interval starting 30 minutes after treatment initiation and ending.
Up to 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2024

Primary Completion (Actual)

January 15, 2025

Study Completion (Actual)

July 15, 2025

Study Registration Dates

First Submitted

November 6, 2024

First Submitted That Met QC Criteria

January 9, 2026

First Posted (Actual)

January 20, 2026

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 9, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Clinical, treatment and logistical data will be anonymously be recorded (ther will be no mention of age, gender, name, letters or numbers to identify participants): IPD will not be collected and therefore not shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Leg Ulcer

Subscribe